The Indian Pharmaceutical sector is highly
fragmented with more than 20,000 registered units. The
leading 250 pharmaceutical companies control 70% of
the market with market leader holding nearly 7% of the
To accelerate growth in this sector the
Government of India allows 100% foreign investment through
the automatic route. Industrial licensing for all bulk
drugs, intermediaries and formulations has been abolished.
The number of drugs under price control has been reduced
from 74 to 28.